The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Epidermal growth factor receptor (EGFR) is a key target in cancer therapy, particularly for non-small cell lung cancer.
• Current EGFR-targeted treatments face challenges including limited efficacy, adverse side effects, and acquired drug resistance.
• Nanotechnology offers novel solutions to enhance molecular targeted cancer therapy.

Purpose of the Study:

• To review the application of inorganic nanoparticles (iNPs) in EGFR-targeted cancer therapy.
• To discuss the advantages of using metal and nonmetallic nanoparticles in this context.
• To highlight future research directions and remaining challenges for EGFR-targeted iNPs.

Main Methods:

• Literature review of inorganic nanoparticles in EGFR-targeted therapy.
• Analysis of typical metal and nonmetallic nanoparticles used.
• Discussion of advantages and future perspectives.

Main Results:

• Inorganic nanoparticles (iNPs) demonstrate potential to overcome limitations in EGFR-targeted cancer therapy.
• Facile preparation, modification, and biosecurity of iNPs are key advantages.
• Various metal and nonmetallic nanoparticles are being explored for enhanced efficacy.

Conclusions:

• Inorganic nanoparticles offer a promising strategy to improve EGFR-targeted cancer treatments.
• Further research is needed to address remaining challenges and optimize iNP applications.
• This review provides insights to inspire future developments in EGFR-targeted nanomedicine.